Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichi Inoue

Showing results (381-390 of 395) with videos related to

Pageof 40
Sort By:
Journal of the American Heart Association|June 15, 2026
Impact of Diabetes on the Efficacy of Low-Voltage Area Ablation for Persistent Atrial Fibrillation: A Subanalysis of the SUPPRESS-AF TrialTatsuhisa Ozaki, Koichi Inoue, Tsuyoshi Mishima, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 16, 2021
Sex Differences in the Efficacy of Pulmonary Vein Isolation Alone vs. Extensive Catheter Ablation in Patients With Persistent Atrial FibrillationTaiki Sato, Yohei Sotomi, Shungo Hikoso, et al.
Clinical Cardiology|July 22, 2021
The efficacy and safety of left atrial low-voltage area guided ablation for recurrence prevention compared to pulmonary vein isolation alone in patients with persistent atrial fibrillation trial: Design and rationaleAkihiro Sunaga, Masaharu Masuda, Koichi Inoue, et al.
European Heart Journal Open|March 9, 2026
Win ratio analysis of low-voltage area ablation in persistent atrial fibrillation: sub-analysis of SUPPRESS-AFAkihiro Sunaga, Yuki Matsuoka, Daisaku Nakatani, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|February 10, 2023
Initial multicenter clinical experience with the first-generation endoscopic guided laser balloon in JapanMasahiko Goya, Kenzo Hirao, Kazutaka Aonuma, et al.
Heart Rhythm|February 2, 2024
Duration of atrial fibrillation persistence: Implications for recurrence risk after catheter ablation and efficacy of additional substrate ablationYasuharu Matsunaga-Lee, Koichi Inoue, Nobuaki Tanaka, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 6, 2026
Complete Low-Voltage Area Ablation in Persistent Atrial Fibrillation - Post Hoc Subanalysis of the SUPPRESS-AF TrialYasuharu Matsunaga-Lee, Yasuyuki Egami, Masaru Abe, et al.
Journal of Thrombosis and Thrombolysis|April 8, 2019
Clinical experience of idarucizumab use in cases of cardiac tamponade under uninterrupted anticoagulation of dabigatran during catheter ablation of atrial fibrillationKaoru Okishige, Yasuteru Yamauchi, Yuichi Hanaki, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 29, 2024
Appropriate Selection of Substrate Ablation for Persistent Atrial Fibrillation Using Intraprocedural AssessmentYasuharu Matsunaga-Lee, Koichi Inoue, Nobuaki Tanaka, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 8, 2026
Concomitant Diabetes Mellitus Diminishes the Efficacy of Left Atrial Additional Ablation Following Pulmonary Vein Isolation - A Subanalysis of the EARNEST-PVI TrialYasuhiro Matsuda, Masaharu Masuda, Nobuaki Tanaka, et al.
Pageof 40

Showing results (381-390 of 395) with videos related to

Sort By:
Pageof 40
Journal of the American Heart Association|June 15, 2026
Impact of Diabetes on the Efficacy of Low-Voltage Area Ablation for Persistent Atrial Fibrillation: A Subanalysis of the SUPPRESS-AF TrialTatsuhisa Ozaki, Koichi Inoue, Tsuyoshi Mishima, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 16, 2021
Sex Differences in the Efficacy of Pulmonary Vein Isolation Alone vs. Extensive Catheter Ablation in Patients With Persistent Atrial FibrillationTaiki Sato, Yohei Sotomi, Shungo Hikoso, et al.
Clinical Cardiology|July 22, 2021
The efficacy and safety of left atrial low-voltage area guided ablation for recurrence prevention compared to pulmonary vein isolation alone in patients with persistent atrial fibrillation trial: Design and rationaleAkihiro Sunaga, Masaharu Masuda, Koichi Inoue, et al.
European Heart Journal Open|March 9, 2026
Win ratio analysis of low-voltage area ablation in persistent atrial fibrillation: sub-analysis of SUPPRESS-AFAkihiro Sunaga, Yuki Matsuoka, Daisaku Nakatani, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|February 10, 2023
Initial multicenter clinical experience with the first-generation endoscopic guided laser balloon in JapanMasahiko Goya, Kenzo Hirao, Kazutaka Aonuma, et al.
Heart Rhythm|February 2, 2024
Duration of atrial fibrillation persistence: Implications for recurrence risk after catheter ablation and efficacy of additional substrate ablationYasuharu Matsunaga-Lee, Koichi Inoue, Nobuaki Tanaka, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 6, 2026
Complete Low-Voltage Area Ablation in Persistent Atrial Fibrillation - Post Hoc Subanalysis of the SUPPRESS-AF TrialYasuharu Matsunaga-Lee, Yasuyuki Egami, Masaru Abe, et al.
Journal of Thrombosis and Thrombolysis|April 8, 2019
Clinical experience of idarucizumab use in cases of cardiac tamponade under uninterrupted anticoagulation of dabigatran during catheter ablation of atrial fibrillationKaoru Okishige, Yasuteru Yamauchi, Yuichi Hanaki, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 29, 2024
Appropriate Selection of Substrate Ablation for Persistent Atrial Fibrillation Using Intraprocedural AssessmentYasuharu Matsunaga-Lee, Koichi Inoue, Nobuaki Tanaka, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 8, 2026
Concomitant Diabetes Mellitus Diminishes the Efficacy of Left Atrial Additional Ablation Following Pulmonary Vein Isolation - A Subanalysis of the EARNEST-PVI TrialYasuhiro Matsuda, Masaharu Masuda, Nobuaki Tanaka, et al.
Pageof 40